Merck Global Health Innovation Group, the corporate venturing unit of US drugs company Merck, has invested $2.5m as the sole investor in the series A round for AdFlow Health Networks, a messaging system for health advice and advertising.
Susan Schramm-Apple at Merck has become a director at AdFlow, according to its regulatory filing.
The $125m Global group was formed in April last year.